Skip to main content

Table 2 Sensitivity analysis for different expressions of Ang-2 between NSCLC tissues and normal tissues

From: Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis

Study omitted Resulting HR (95 % CI)
None 0.87 (0.56–1.18)
Li 2005 0.89 (0.52–1.25)
Liu 2014 0.73 (0.50–0.96)
Park 2007 0.90 (0.47–1.32)
Park 2009 0.98 (0.69–1.27)
Wan 2008 0.85 (0.44–1.26)